Anthony Bunn
Secrétaire Général chez De Novo Pharmaceuticals Ltd.
Postes actifs de Anthony Bunn
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
De Novo Pharmaceuticals Ltd.
 De Novo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology De Novo Pharmaceuticals Ltd. discovers and develops drugs. It is a novel molecular structure generating drug discovery platform targeting pathogenic bacteria. The firm offers lower cost, rapid, lower molecular weights hits, novel, and patentable hit molecules. The company was founded by David Bailey, Iwan de Esch, and Philip Dean M on April 28, 1999 and is headquartered in London, the United Kingdom. | Secrétaire Général | 01/09/2000 | - |
| Comptroller/Controller/Auditor | - | - |
Historique de carrière de Anthony Bunn
Anciens postes connus de Anthony Bunn
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SAREUM HOLDINGS PLC | Secrétaire Général | 22/09/2009 | 07/01/2022 |
Statistiques
Internationale
| Royaume-Uni | 3 |
Opérationnelle
| Corporate Secretary | 2 |
| Comptroller/Controller/Auditor | 1 |
Sectorielle
| Health Technology | 2 |
| Miscellaneous | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SAREUM HOLDINGS PLC | Miscellaneous |
| Entreprise privées | 1 |
|---|---|
De Novo Pharmaceuticals Ltd.
De Novo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology De Novo Pharmaceuticals Ltd. discovers and develops drugs. It is a novel molecular structure generating drug discovery platform targeting pathogenic bacteria. The firm offers lower cost, rapid, lower molecular weights hits, novel, and patentable hit molecules. The company was founded by David Bailey, Iwan de Esch, and Philip Dean M on April 28, 1999 and is headquartered in London, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Anthony Bunn
- Expérience
